4.7 Article

Host Gene Expression in Nose and Blood for the Diagnosis of Viral Respiratory Infection

期刊

JOURNAL OF INFECTIOUS DISEASES
卷 219, 期 7, 页码 1151-1161

出版社

OXFORD UNIV PRESS INC
DOI: 10.1093/infdis/jiy608

关键词

diagnosis; human gene expression; microarray; respiratory viruses; viral infection

资金

  1. National Institute of Allergy and Infectious Diseases, Division of Microbiology and Infectious Diseases, NIH, Department of Health and Human Services [HHSN272201200005C]
  2. National Cancer Institute Cancer Center Support Grant [P30 CA91842]
  3. Institute of Clinical and Translational Sciences/ Clinical and Translational Sciences Award from the NCRR, a component of NIH [UL1TR002345]
  4. NIH Roadmap for Medical Research

向作者/读者索取更多资源

Background. Recently there has been a growing interest in the potential for host transcriptomic analysis to augment the diagnosis of infectious diseases. Methods. We compared nasal and blood samples for evaluation of the host transcriptomic response in children with acute respiratory syncytial virus (RSV) infection, symptomatic non-RSV respiratory virus infection, asymptomatic rhinovirus infection, and virus-negative asymptomatic controls. We used nested leave-one-pair-out cross-validation and supervised principal components analysis to define small sets of genes whose expression patterns accurately classified subjects. We validated gene classification scores using an external data set. Results. Despite lower quality of nasal RNA, the number of genes detected by microarray in each sample type was equivalent. Nasal gene expression signal derived mainly from epithelial cells but also included a variable leukocyte contribution. The number of genes with increased expression in virus-infected children was comparable in nasal and blood samples, while nasal samples also had decreased expression of many genes associated with ciliary function and assembly. Nasal gene expression signatures were as good or better for discriminating between symptomatic, asymptomatic, and uninfected children. Conclsusions. Our results support the use of nasal samples to augment pathogen-based tests to diagnose viral respiratory infection.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Cellular Cytotoxicity of Next-Generation CD20 Monoclonal Antibodies

Karl R. VanDerMeid, Michael R. Elliott, Andrea M. Baran, Paul M. Barr, Charles C. Chu, Clive S. Zent

CANCER IMMUNOLOGY RESEARCH (2018)

Article Hematology

Long-term results of a pilot study evaluating hyperbaric oxygen therapy to improve umbilical cord blood engraftment

Alain Mina, Leyla Shune, Haitham Abdelhakim, Tara L. Lin, Sid Ganguly, Andrea Baran, Anurag Singh, Sunil Abhyankar, Joseph P. McGuirk, Dennis Allin, Omar S. Aljitawi

ANNALS OF HEMATOLOGY (2019)

Article Oncology

Ibrutinib Dose Adherence and Therapeutic Efficacy in Non-Hodgkin Lymphoma: A Single-Center Experience

AnnaLynn M. Williams, Andrea M. Baran, Carla Casulo, Patrick Reagan, Jonathan W. Friedberg, Margaret Helber, Jeremiah Moore, Elizabeth Baloga, Clive S. Zent, Paul M. Barr

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2019)

Review Oncology

Systematic Review of Randomized Controlled Trials of Exercise Interventions Using Digital Activity Trackers in Patients With Cancer

Kerry Schaffer, Narmadha Panneerselvam, Kah Poh Loh, Rachel Herrmann, Ian R. Kleckner, Richard Francis Dunne, Po-Ju Lin, Charles E. Heckler, Nicholas Gerbino, Lauren B. Bruckner, Eugene Storozynsky, Bonnie Ky, Andrea Baran, Supriya Gupta Mohile, Karen Michelle Mustian, Chunkit Fung

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)

Article Oncology

Evaluation of the clinical impact of concomitant acid suppression therapy in colorectal cancer patients treated with capecitabine monotherapy

Hannah E. Rhinehart, Michelle A. Phillips, Nathaniel Wade, Andrea Baran

JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2019)

Article Hematology

Results of the First Clinical Study in Humans That Combines Hyperbaric Oxygen Pretreatment with Autologous Peripheral Blood Stem Cell Transplantation

Haitham Abdelhakim, Leyla Shune, Sajjad Bhatti, Amy Rose Cantilena, Andrea Baran, Tara L. Lin, Siddhartha Ganguly, Anurag K. Singh, Sunil Abhyankar, Clint Divine, Brea Lipe, Joseph McGuirk, Dennis Allin, Omar S. Aljitawi

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)

Letter Oncology

Patients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretation

Kah Poh Loh, Andrea Baran, Christina Y. Lee, Alfadel Alshaibani, Sarah C. Rutherford, John Hu, Carla Casulo, Paul M. Barr, Jonathan W. Friedberg, Patrick M. Reagan

LEUKEMIA & LYMPHOMA (2019)

Letter Hematology

Significant weight gain in CLL patients treated with Ibrutinib: A potentially deleterious consequence of therapy

AnnaLynn M. Williams, Andrea M. Baran, Mahlon Schaffer, Jocelyn Bushart, Lynn Rich, Jeremiah Moore, Paul M. Barr, Clive S. Zent

AMERICAN JOURNAL OF HEMATOLOGY (2020)

Article Immunology

Non-donor specific anti-human leukocyte antigen (HLA) antibodies are not associated with poor outcome in hematopoietic stem cell transplant recipients

J. R. Andolina, R. Walia, J. Oliva, A. Baran, J. Liesveld, M. W. Becker, A. Busacco, M. Coppage

HUMAN IMMUNOLOGY (2020)

Article Oncology

Toxicity patterns of novel PI3K combinations in patients with non-Hodgkin lymphoma

Thomas D. Rodgers, AnnaLynn M. Williams, Andrea Baran, Patrick M. Reagan, Carla Casulo, Clive S. Zent, Andrew Evans, Jonathan W. Friedberg, Paul M. Barr

Summary: A retrospective review of 79 patients found that patients receiving novel combination therapy and previously untreated patients were more likely to develop severe adverse events. This suggests caution against the use of untested PI3K inhibitor combinations in routine practice.

LEUKEMIA & LYMPHOMA (2021)

Article Oncology

A phase II study of sequential decitabine and rapamycin in acute myelogenous leukemia

Jane L. Liesveld, Andrea Baran, Mitra Azadniv, Haley Misch, Katherine Nedrow, Michael Becker, Kah Poh Loh, Kristen M. O'Dwyer, Jason H. Mendler

Summary: The phase II study aimed to investigate whether sequential exposure to decitabine followed by rapamycin would result in better responses in AML patients. Despite not meeting its primary endpoint, the survival rates in relapsed/refractory cases seem comparable to other salvage regimens, and the de novo group had a significantly higher composite CR rate compared to decitabine alone.

LEUKEMIA RESEARCH (2022)

Article Biology

A curated human cellular microRNAome based on 196 primary cell types

Arun H. Patil, Andrea Baran, Zachary P. Brehm, Matthew N. McCall, Marc K. Halushka

Summary: This study provides the most complete reference to date of miRNA expression patterns by human primary cell types, shedding light on the regulatory role of miRNAs in different cell types.

GIGASCIENCE (2022)

Article Oncology

Building a High-Dose-Rate Prostate Brachytherapy Program With Real-Time Ultrasound-Based Planning: Initial Safety, Quality, and Outcome Results

Hong Zhang, Sohyun Kang, Naba Ali, Andrea Baran, Kevin Bylund, David Gentile, Gregory Previte, Ahmad Matloubieh, Alex Gray, Nancy Marou

ADVANCES IN RADIATION ONCOLOGY (2020)

Article Medicine, Research & Experimental

T cell developmental arrest in former premature infants increases risk of respiratory morbidit later in infancy

Kristin M. Scheible, Jason Emo, Nathan Laniewski, Andrea M. Baran, Derick R. Peterson, Jeanne Holden-Wiltse, Sanjukta Bandyopadhyay, Andrew G. Straw, Heidie Huyck, John M. Ashton, Kelly Schooping Tripi, Karan Arul, Elizabeth Werner, Tanya Scalise, Deanna Maffett, Mary Caserta, Rita M. Ryan, Anne Marie Reynolds, Clement L. Ren, David J. Topham, Thomas J. Mariani, Gloria S. Pryhuber

JCI INSIGHT (2018)

暂无数据